DK0972520T3 - Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52 - Google Patents

Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52

Info

Publication number
DK0972520T3
DK0972520T3 DK98901044T DK98901044T DK0972520T3 DK 0972520 T3 DK0972520 T3 DK 0972520T3 DK 98901044 T DK98901044 T DK 98901044T DK 98901044 T DK98901044 T DK 98901044T DK 0972520 T3 DK0972520 T3 DK 0972520T3
Authority
DK
Denmark
Prior art keywords
freeze
bone morphogenetic
morphogenetic protein
human bone
dried composition
Prior art date
Application number
DK98901044T
Other languages
Danish (da)
English (en)
Inventor
Mitsuko Inagaki
Hideki Hoechst Marion Ichikawa
Original Assignee
Bioph Biotech Entw Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioph Biotech Entw Pharm Gmbh filed Critical Bioph Biotech Entw Pharm Gmbh
Application granted granted Critical
Publication of DK0972520T3 publication Critical patent/DK0972520T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1875Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98901044T 1997-01-30 1998-01-29 Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52 DK0972520T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1634997 1997-01-30
PCT/JP1998/000371 WO1998033514A1 (fr) 1997-01-30 1998-01-29 Composition lyophilisee de mp52 humaine de proteines morphogenetiques osseuses

Publications (1)

Publication Number Publication Date
DK0972520T3 true DK0972520T3 (da) 2005-12-19

Family

ID=11913900

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98901044T DK0972520T3 (da) 1997-01-30 1998-01-29 Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52

Country Status (22)

Country Link
EP (1) EP0972520B9 (sl)
JP (1) JP4209948B2 (sl)
KR (1) KR100548107B1 (sl)
CN (1) CN1152712C (sl)
AP (1) AP983A (sl)
AT (1) ATE302021T1 (sl)
AU (1) AU737595B2 (sl)
BR (1) BR9807537B1 (sl)
CA (1) CA2278546C (sl)
DE (1) DE69831223T9 (sl)
DK (1) DK0972520T3 (sl)
EA (1) EA001579B1 (sl)
ES (1) ES2244043T3 (sl)
HU (1) HU226554B1 (sl)
IL (2) IL130967A0 (sl)
NO (1) NO322334B1 (sl)
NZ (1) NZ336509A (sl)
PL (1) PL189381B1 (sl)
RS (1) RS49691B (sl)
SI (1) SI0972520T1 (sl)
TR (1) TR199901832T2 (sl)
WO (1) WO1998033514A1 (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE239514T1 (de) 1997-02-07 2003-05-15 Stryker Corp Matrixlose osteogene vorrichtungen und implantate und verfahren zu deren verwendung
EP1434569A1 (en) * 2001-10-09 2004-07-07 CellFactors plc Therapeutic biological product and method for formation of new vascularised bone
DK1448246T4 (en) 2001-11-19 2015-12-21 Scil Technology Gmbh Homogeneously coated device with osteoinductive and osteoconductive properties
DK1539261T3 (da) 2002-09-10 2006-08-07 Scil Technology Gmbh Metalimplantat belagt under nedsat oxygenkoncentration med osteoinduktiv protein
EP1651272A1 (en) * 2003-08-05 2006-05-03 Fuji Photo Film B.V. Use of recombinant or synthetic gelatin as a stabiliser in vaccines
AU2004288854B2 (en) * 2003-11-10 2009-10-01 Arriva-Pharmaceuticals, Inc. Dry recombinant human alpha 1-antitrypsin formulation
PL1737734T3 (pl) 2004-03-10 2011-02-28 Scil Tech Gmbh Powlekane implanty, ich wytwarzanie i zastosowanie
US20160344677A1 (en) 2015-05-22 2016-11-24 Microsoft Technology Licensing, Llc Unified messaging platform for providing interactive semantic objects
US10360287B2 (en) 2015-05-22 2019-07-23 Microsoft Technology Licensing, Llc Unified messaging platform and interface for providing user callouts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
ATE142460T1 (de) * 1991-06-21 1996-09-15 Genetics Inst Osteogene proteine enthaltende arzneimittel
JP2966592B2 (ja) * 1991-07-20 1999-10-25 萩原 義秀 安定化されたヒトモノクローナル抗体製剤
NZ249113A (en) * 1992-02-12 1996-07-26 Bioph Biotech Entw Pharm Gmbh Recombinant dna encoding tgf-b, its production and pharmaceutical compositions thereof
CA2093836A1 (en) * 1992-04-24 1993-10-25 Wayne Gombotz Biodegradable tgf-.beta. delivery system for bone regeneration
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
DE69524456T2 (de) * 1995-03-21 2002-08-01 Applied Research Systems Flüssige hcg-formulierungen
PL186518B1 (pl) * 1995-04-19 2004-01-30 Bioph Biotech Entw Pharm Gmbh Białko, kompozycja farmaceutyczna i sposób wytwarzania białka

Also Published As

Publication number Publication date
CA2278546A1 (en) 1998-08-06
JP4209948B2 (ja) 2009-01-14
AU5679198A (en) 1998-08-25
BR9807537B1 (pt) 2009-01-13
EP0972520A1 (en) 2000-01-19
EA199900694A1 (ru) 2000-04-24
DE69831223D1 (de) 2005-09-22
EP0972520A4 (en) 2002-11-05
HUP0002386A2 (hu) 2000-11-28
DE69831223T9 (de) 2006-12-07
NZ336509A (en) 2001-03-30
NO993702L (no) 1999-09-29
PL189381B1 (pl) 2005-07-29
EA001579B1 (ru) 2001-06-25
IL130967A (en) 2006-12-10
EP0972520B9 (en) 2006-03-22
WO1998033514A1 (fr) 1998-08-06
YU34999A (sh) 2002-08-12
CN1152712C (zh) 2004-06-09
PL334852A1 (en) 2000-03-27
AP983A (en) 2001-07-16
BR9807537A (pt) 2000-03-21
IL130967A0 (en) 2001-01-28
CN1244127A (zh) 2000-02-09
AU737595B2 (en) 2001-08-23
ES2244043T3 (es) 2005-12-01
EP0972520B1 (en) 2005-08-17
RS49691B (sr) 2007-12-31
HUP0002386A3 (en) 2002-09-30
ATE302021T1 (de) 2005-09-15
KR100548107B1 (ko) 2006-02-02
DE69831223T2 (de) 2006-02-16
SI0972520T1 (sl) 2006-02-28
HU226554B1 (en) 2009-03-30
AP9901602A0 (en) 1999-09-30
KR20000070586A (ko) 2000-11-25
CA2278546C (en) 2008-04-01
NO993702D0 (no) 1999-07-29
NO322334B1 (no) 2006-09-18
TR199901832T2 (xx) 1999-12-21

Similar Documents

Publication Publication Date Title
FI990596A0 (fi) Luun morfogeneettiset proteiini-16 (BMP-16) -koostumukset
FR2751202B1 (fr) Implant squelettique
NO965208D0 (no) Benprotese
DE69715264D1 (de) Knochenprothese
DE69630933D1 (de) Hohle Knochenprothese mit angepasster Flexibilität
FR2787020B1 (fr) Implant intervertebral
DE69715348T2 (de) Hüftgelenkprothese
FR2759576B1 (fr) Implant de sclero-keratectomie pre-descemetique
FR2722980B1 (fr) Implant vertebral inter-epineux
DE69711103D1 (de) Tibiale Prothese
MA26545A1 (fr) Procedes de cicatrisation des os
FR2734709B1 (fr) Prothese totale de genou
EP1095159A4 (en) Bone Morphogenetic Protein
ATA144897A (de) Wirbelsäulen-prothese
DK0972520T3 (da) Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
FR2767062B1 (fr) Composition comprenant de la propolis
DE29703971U1 (de) Knochenprothese
FR2751528B1 (fr) Prothese de hanche
DE29712331U1 (de) Implantat zur Befestigung von Wirbeln
EE9900092A (et) PTX-tundlikud G-valgud, nende valmistamine ja kasutamine
FR2760966B1 (fr) Prothese de hanche
DE69621892T2 (de) Gruppen von Haarprothesen zur Kalheitsreduzierung
NO964545D0 (no) Benprotese
FR2755004B1 (fr) Prothese de genou